Literature DB >> 22592801

Tumor suppressor p53 (TP53) at the crossroads of the exposome and the cancer genome.

Aaron J Schetter1, Curtis C Harris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22592801      PMCID： PMC3361405          DOI： 10.1073/pnas.1205457109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  20 in total

Review 1.  Complementing the genome with an "exposome": the outstanding challenge of environmental exposure measurement in molecular epidemiology.

Authors:  Christopher Paul Wild
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-08       Impact factor: 4.254

Review 2.  Initial impact of the sequencing of the human genome.

Authors:  Eric S Lander
Journal:  Nature       Date:  2011-02-10       Impact factor: 49.962

3.  Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa.

Authors:  B Bressac; M Kew; J Wands; M Ozturk
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

Review 4.  Mutant p53 gain-of-function in cancer.

Authors:  Moshe Oren; Varda Rotter
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-02       Impact factor: 10.005

Review 5.  TP53 mutations in human cancers: origins, consequences, and clinical use.

Authors:  Magali Olivier; Monica Hollstein; Pierre Hainaut
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-01       Impact factor: 10.005

6.  Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors.

Authors:  D Sidransky; T Tokino; S R Hamilton; K W Kinzler; B Levin; P Frost; B Vogelstein
Journal:  Science       Date:  1992-04-03       Impact factor: 47.728

7.  Epidemiology. Environment and disease risks.

Authors:  Stephen M Rappaport; Martyn T Smith
Journal:  Science       Date:  2010-10-22       Impact factor: 47.728

Review 8.  p53 mutations in human cancers.

Authors:  M Hollstein; D Sidransky; B Vogelstein; C C Harris
Journal:  Science       Date:  1991-07-05       Impact factor: 47.728

9.  A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma.

Authors:  D E Brash; J A Rudolph; J A Simon; A Lin; G J McKenna; H P Baden; A J Halperin; J Pontén
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

10.  Integrated genomic analyses of ovarian carcinoma.

Authors: 
Journal:  Nature       Date:  2011-06-29       Impact factor: 49.962
View more
  8 in total

Review 1.  Blood-borne biomarkers and bioindicators for linking exposure to health effects in environmental health science.

Authors:  M Ariel Geer Wallace; Tzipporah M Kormos; Joachim D Pleil
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2016-10-19       Impact factor: 6.393

2.  A novel p53 mutant found in iatrogenic urothelial cancers is dysfunctional and can be rescued by a second-site global suppressor mutation.

Authors:  Adam F Odell; Luke R Odell; Jon M Askham; Hiba Alogheli; Sreenivasan Ponnambalam; Monica Hollstein
Journal:  J Biol Chem       Date:  2013-04-23       Impact factor: 5.157

Review 3.  Clinical Outcomes of TP53 Mutations in Cancers.

Authors:  Ana I Robles; Jin Jen; Curtis C Harris
Journal:  Cold Spring Harb Perspect Med       Date:  2016-09-01       Impact factor: 6.915

4.  TP53 mutations induced by BPDE in Xpa-WT and Xpa-Null human TP53 knock-in (Hupki) mouse embryo fibroblasts.

Authors:  Jill E Kucab; Harry van Steeg; Mirjam Luijten; Heinz H Schmeiser; Paul A White; David H Phillips; Volker M Arlt
Journal:  Mutat Res       Date:  2015-01-30       Impact factor: 2.433

5.  Interactions of chromatin context, binding site sequence content, and sequence evolution in stress-induced p53 occupancy and transactivation.

Authors:  Dan Su; Xuting Wang; Michelle R Campbell; Lingyun Song; Alexias Safi; Gregory E Crawford; Douglas A Bell
Journal:  PLoS Genet       Date:  2015-01-08       Impact factor: 5.917

Review 6.  Chinese herbs containing aristolochic acid associated with renal failure and urothelial carcinoma: a review from epidemiologic observations to causal inference.

Authors:  Hsiao-Yu Yang; Pau-Chung Chen; Jung-Der Wang
Journal:  Biomed Res Int       Date:  2014-08-27       Impact factor: 3.411

7.  TP53 and lacZ mutagenesis induced by 3-nitrobenzanthrone in Xpa-deficient human TP53 knock-in mouse embryo fibroblasts.

Authors:  Jill E Kucab; Edwin P Zwart; Harry van Steeg; Mirjam Luijten; Heinz H Schmeiser; David H Phillips; Volker M Arlt
Journal:  DNA Repair (Amst)       Date:  2015-12-08

8.  Anomalous altered expressions of downstream gene-targets in TP53-miRNA pathways in head and neck cancer.

Authors:  Sanga Mitra; Nupur Mukherjee; Smarajit Das; Pijush Das; Chinmay Kumar Panda; Jayprokas Chakrabarti
Journal:  Sci Rep       Date:  2014-09-04       Impact factor: 4.379
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.